Company: MBIO
Filing Date: 2025-04-01
Form Type: 424B3
Source: 0001104659-25-030657
Chunk: 108

Company: MUSTANG BIO, INC.
Filing Date: 2025-04-01
Form: 424B3
Chunk 108
---
, which could depress the trading price of our common stock or cause it to continue
to be highly volatile or subject to wide fluctuations. Some of the factors that could negatively affect our share price or result in fluctuations
in the price or trading volume of our common stock include, among other things:

| · | the commencement, enrollment, or results of our current and future preclinical studies and clinical trials, and the results of trials of our competitors or those of other companies in our market sector; |

​

| · | regulatory approval of our product candidates, or limitations to specific label indications or patient populations for its use, or changes or delays in the regulatory review process; |

​

| · | manufacturing, supply or distribution delays or shortages; |

​

| · | our ability to identify and successfully acquire or in-license new product candidates on acceptable terms; |

​

| · | FDA, state or international regulatory actions, including actions on regulatory applications any of our product candidates; |

​

| · | legislative or regulatory changes; |

​

| · | judicial pronouncements interpreting laws and regulations; |

| · | changes in government programs; |

​

| · | announcements of new products, services or technologies, commercial relationships, acquisitions or other events by us or our competitors; |

​

| · | market conditions in the pharmaceutical and biotechnology sectors; |

​

| · | fluctuations in stock market prices and trading volumes of similar companies; |

​

| · | changes in accounting principles; |

​

| · | litigation or public concern about the safety of our product candidates or similar product candidates; |

​

| · | sales of large blocks of our common stock, including sales by our executive officers, directors and significant shareholders; and |

​

| · | our ability to obtain additional financing to advance our development operations. |

​

These broad market and industry factors may decrease
the market price of our common stock, regardless of our actual operating performance. The stock market in general has from time to time
experienced extreme price and volume fluctuations. In addition, in the past, following periods of volatility in the overall market and
decreases in the market price of a company’s securities, securities class action litigation has often been instituted against these
companies. This litigation, if instituted against us, could result in substantial costs and a diversion of our management’s attention
and resources.

​

We may become involved in securities class action litigation that could divert management’s attention and harm our business.

The stock markets have from time to time experienced
significant price and volume fluctuations that have affected